Development of a high-throughput method for the determination of pharmacological levels of plasma D-serine.
Development of a high-throughput method for the determination of pharmacological levels of plasma D-serine.
复制标题
DOI:
10.1016/j.ab.2011.08.018
复制
发表时间:
2011-12-15
影响因子:
2.9
通讯作者:
Slusher B
中科院分区:
文献类型:
--
作者:
Alt J;Rojas C;Wozniak K;Wu Y;Ferraris D;Tsukamoto T;Slusher B
D-serine administration has been shown to be effective for the treatment of schizophrenia symptoms. However, D-serine has to be administered at high doses in order to observe clinical effects. This is in large part due to D-serine undergoing oxidation by D-amino acid oxidase (DAAO) before it reaches the brain. Consequently, co-administration of D-serine with a DAAO inhibitor has been suggested as a way to lower the dose of D-serine required to treat schizophrenia. During the characterization of DAAO inhibitors as potential drugs, inhibitors are evaluated in rodents for their ability to increase plasma D-serine levels after oral co-administration. Current HPLC-based methodologies to measure D-serine in plasma are time consuming and are not amenable to concomitant analysis of multiple samples. We report the characterization of a 96-well-format assay to monitor D-serine in plasma that greatly expedites analysis time. The assay involves the use of strong cation exchange solid phase extraction (SPE) to isolate D-serine from plasma followed by quantitation of D-serine using the DAAO catalyzed reaction. Plasma D-serine determination using this assay could also be used as pharmacodynamic marker and as biomarker.
登录
查看更多内容
影响因子:
--
作者:
Brandish, Philip E.;Chiu, Chi-Sung;Zheng, Wei
通讯作者:
Zheng, Wei
影响因子:
1.8
作者:
Fukushima, T;Kawai, J;Toyo'oka, T
通讯作者:
Toyo'oka, T
影响因子:
10.6
作者:
Tsai, GC;Yang, PC;Coyle, JT
通讯作者:
Coyle, JT
DOI:
10.1124/jpet.108.147884
发表时间:
2009-03-01
影响因子:
3.5
作者:
Smith, Sean M.;Uslaner, Jason M.;Hutson, Peter H.
通讯作者:
Hutson, Peter H.
影响因子:
10.6
作者:
Heresco-Levy, U;Javitt, DC;Ermilov, M
通讯作者:
Ermilov, M